FDA Inspection 1065402 — Catherine Donovan, M.D.
The FDA completed an inspection of Catherine Donovan, M.D. on Aug 23, 2018 in St Johns. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 23, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- St Johns (Netherlands)
Additional Details
Clinical Investigator (CI)